Tag Archives: formulations

Meta-analysis finds no real difference in safety and effectiveness between tenofovir formulations

There are no real differences between tenofovir formulations – tenofovir disoproxil fumarate (TDF) and tenofovir alafenamide (TAF) – in terms of viral suppression and bone and renal safety, according to a systematic review and meta-analysis published in AIDS. The newer formulation of the drug (TAF) only showed superiority in terms of efficacy, and then to a modest… Read More »